Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
148.83
-0.23 (-0.15%)
At close: May 9, 2025, 4:00 PM
148.83
0.00 (0.00%)
After-hours: May 9, 2025, 7:50 PM EDT
Tenet Healthcare Stock Forecast
Stock Price Forecast
According to 16 professional analysts, the 12-month price target for Tenet Healthcare stock ranges from a low of $137 to a high of $230. The average price target of $173.31 forecasts a 16.45% increase in the stock price over the next year.
Price Target: $173.31 (+16.45%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Tenet Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Buy | 9 | 10 | 10 | 11 | 9 | 9 |
| Hold | 3 | 3 | 3 | 3 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 18 | 18 | 19 | 18 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $134 → $154 | Hold | Maintains | $134 → $154 | +3.47% | May 5, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $165 → $175 | Buy | Maintains | $165 → $175 | +17.58% | May 5, 2025 |
| Barclays | Barclays | Buy Maintains $161 → $171 | Buy | Maintains | $161 → $171 | +14.90% | Apr 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $183 → $189 | Buy | Maintains | $183 → $189 | +26.99% | Apr 30, 2025 |
| UBS | UBS | Strong Buy Maintains $217 → $230 | Strong Buy | Maintains | $217 → $230 | +54.54% | Apr 30, 2025 |
Financial Forecast
Revenue This Year
21.09B
from 20.67B
Increased by 2.04%
Revenue Next Year
22.17B
from 21.09B
Increased by 5.14%
EPS This Year
12.28
from 32.70
Decreased by -62.45%
EPS Next Year
13.34
from 12.28
Increased by 8.66%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.2B | 23.4B | 24.6B | ||
| Avg | 21.1B | 22.2B | 23.3B | ||
| Low | 20.2B | 21.2B | 22.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.7% | 10.9% | 11.1% | ||
| Avg | 2.0% | 5.1% | 5.1% | ||
| Low | -2.2% | 0.7% | -0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.34 | 15.26 | 17.76 | ||
| Avg | 12.28 | 13.34 | 15.20 | ||
| Low | 11.34 | 11.23 | 12.33 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -59.2% | 24.3% | 33.1% | ||
| Avg | -62.4% | 8.7% | 13.9% | ||
| Low | -65.3% | -8.5% | -7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.